Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices
Today's biggest winners and losers in the stock market. On this episode of Stock Movers:- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.